Skip to main content
SpringerLink
Log in

Gemcadiol: A new antilipemic drug, a clinical trial

  • Symposium: Hyperlipidemia Presented at the AOCS 67 th Annual Spring Meeting New Orleans, Louisiana
  • Published:
Lipids

Abstract

Nineteen patients with Type II, III, IV, or V hyperlipoproteinemia received gemcadiol (2,2,9,9,-tetramethyl-1,10-decanediol) in daily doses between 1.2 and 2 g. The patients were hospitalized for dose titration and then followed as outpatients on appropriate doses of gemcadiol. In Type II hyperlipoproteinemia, serum cholesterol was lowered by an average of 24%. The serum triglycerides in Type IV hyperlipoproteinemia decreased by an average of 51%. Serum uric acid was not altered. There were no changes of subjective feelings or of clinical or laboratory findings, including creatine phosphokinase. This study indicates that gemcadiol is an effective antilipemic agent that is very well tolerated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henry, R.J., Clinical Chemistry, Principles and Techniques, Harper & Row, Publishers, Incorporated, New York, N.Y., 1967, p. 847.

    Google Scholar 

  2. Eggstein, M., and F.H. Schmidt, Klin. Wschr. 44:267 (1966).

    Article  PubMed  CAS  Google Scholar 

  3. Dunn, O.J., Technometrics 6:241 (1964).

    Article  Google Scholar 

  4. Hollander, M., and D.A. Wolfe, “Non-parametric Statistical Methods,” John Wiley & Sons, New York, NY, 1973.

    Google Scholar 

  5. Berkowitz, D., J. Am. Med. Assoc. 218:1002 (1971).

    Article  CAS  Google Scholar 

  6. Jain, A., J.R. Ryan, D. Hague, and F.G. McMahon, Clin. Pharmacol. Therap. 11:551 (1970).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Therapeutics Section, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana

    H. Peter Blumenthal, Jerome R. Ryan, Adesh K. Jain & F. Gilbert McMahon

Authors
  1. H. Peter Blumenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerome R. Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adesh K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Gilbert McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Blumenthal, H.P., Ryan, J.R., Jain, A.K. et al. Gemcadiol: A new antilipemic drug, a clinical trial. Lipids 12, 44–48 (1977). https://doi.org/10.1007/BF02532970

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02532970

Keywords

Search

Navigation